Trademark Alertz ®
Search
Trademark
Owner
Trademark: GOVUSTO 2076644
Word
GOVUSTO
ID
2076644
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
16 January 2020
Registration Date
16 January 2020
Renewal Date
16 January 2030
Owner(s)
Tessa Therapeutics Ltd
Service
Goods and Services:
Class 1
:
Chemical and biochemical reagents, for scientific and research use and for use in biotechnological manufacturing processes, for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells
;
chemical reagents, for scientific and research use and for use in biotechnological manufacturing processes, for the stimulation and/or expansion of T cells or B cells
;
kits comprising chemical reagents and biochemical reagents, for scientific and research use and for use in biotechnological manufacturing processes, for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells
;
kits comprising chemical reagents and biochemical reagents, for scientific and research use and for use in biotechnological manufacturing processes, for the stimulation and/or expansion of T cells or B cells
;
chemical, biochemical and biotechnological products for industrial and scientific purposes
;
chemical, biochemical and biotechnological products for use in research and test laboratories
;
chemical, biochemical and biotechnological products
;
reagents for the preparation or transport of biological molecules.
Class 5
:
Pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer and autoimmune diseases for scientific, clinical, medicinal, therapeutic, and diagnostic purposes
;
pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of cancer and autoimmune disease
;
pharmaceutical preparations for T-cell therapy
;
biological preparations for the treatment of cancer and autoimmune disease
;
medical preparations for therapeutic purposes
;
preparations for cell therapy
;
preparations for cancer therapies
;
chimeric antigen receptors (CAR) and therapeutic preparations thereof
;
antibodies
;
preparations for genetically modifying human cells for medical purposes, including viral vectors
;
preparations of blood extracted from humans which have been adapted for therapeutic purposes
;
biopharmaceutical agents in the form of oncolytic viruses for the prevention, diagnosis, and treatment of cancer and autoimmune disease.